Spatiotemporally Precise Rheumatoid Arthritis Therapy via a Triple‐Locked Cascaded Nanoplatform With Dual‐Channel Self‐Reporting
Open Access
- 22 October 2026
- journal article
- research article
- Published by Wiley in Advanced Science
- p. e78405
Abstract
Achieving precise spatiotemporal control over combination therapies in rheumatoid arthritis (RA) remains heavily compromised by conventional nanoplatforms, which typically suffer from premature off‐target leakage, coupled drug release, and inadequate in vivo tracking capabilities. Herein, a programmable orthogonally branched triple‐locked nanotheranostic platform (MB@YW NPs) is engineered to seamlessly synchronize spatial localization, chemically orthogonal multidrug liberation, and real‐time multichannel self‐reporting. The system comprises a pH‐responsive polymeric matrix co‐encapsulating a HOCl‐activatable methotrexate prodrug (MB‐MTX) and an ONOO − /light‐responsive sulfasalazine prodrug (YW‐SSZ). Precluding systemic leakage, synovial acidity dictates initial spatial targeting by triggering tissue‐specific disassembly and subsequent macrophage internalization. Subsequently, non‐interfering pathophysiological triggers exclusively liberate distinct therapeutics through independent pathways: intracellular HOCl purely unlocks methotrexate with concomitant near‐infrared “turn‐on” fluorescence, whereas an isolated ONOO − /light sequence locally activates sulfasalazine accompanied by a blue “on‐to‐off” readout. This lack of cross‐talk successfully discriminates multiplexed activation states. In vivo, this triple‐locked platform efficiently alleviates oxidative stress and remodels the inflammatory microenvironment, leading to markedly suppressed joint destruction in collagen‐induced arthritis models. Furthermore, transcriptomic analysis reveals these synergistic macroscopic benefits are driven by targeted modulation of the cAMP/NF‐κB signaling axis. Collectively, this work establishes a transformative and generalizable framework for independently coordinated, next‐generation precision multi‐prodrug nanomedicine.Keywords
Funding Information
- National Key Research and Development Program of China (2024YFA1803501)
- National Natural Science Foundation of China (T2488302)
- National Natural Science Foundation of China (22404056)
- Science and Technology Commission of Shanghai Municipality (24DX1400200)
This publication has 61 references indexed in Scilit:
- Remote Molecule Activation in Living Mice Triggered by Therapeutic UltrasoundAngewandte Chemie, 2026
- Dual Enzyme‐Responsive Polymer‐Drug Conjugates Induce Diverse Cells Mutual Transcytosis to Achieve Deep Pancreatic Tumor PenetrationAngewandte Chemie, 2025
- Microenvironment‐Activatable Probe for Precise NIR‐II Monitoring and Synergistic Immunotherapy in Rheumatoid ArthritisAdvanced Materials, 2024
- A multifunctional nanoaggregate‐based system for detection of rheumatoid arthritis via Optoacoustic/NIR‐II fluorescent imaging and therapy via inhibiting JAK‐STAT/NF‐κB/NLRP3 pathwaysAggregate, 2023
- Tannic Acid‐Based Nanomaterials for Tolerogenic Immunotherapy of Rheumatoid ArthritisAdvanced Functional Materials, 2023
- Dual‐Triggered Near‐Infrared Persistent Luminescence Nanoprobe for Autofluorescence‐Free Imaging‐Guided Precise Therapy of Rheumatoid ArthritisAdvanced Science, 2022
- Biomimetic and Bioinspired Intervention Strategies for the Treatment of Rheumatoid ArthritisAdvanced Functional Materials, 2021
- Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular NanoformulationsAdvanced Materials, 2021
- Harnessing Hypoxia‐Dependent Cyanine Photocages for In Vivo Precision Drug ReleaseAngewandte Chemie, 2021
- Release of Amino‐ or Carboxy‐Containing Compounds Triggered by HOCl: Application for Imaging and Drug DesignAngewandte Chemie, 2019